"Drugs with advantageous safety profiles, in particular drugs that avoid daytime carryover, are not going to make headway with psychiatrists who as a group are prescribing Valium and Xanax during the daytime, " says Gary Richardson, a senior research scientist at the Henry Ford Hospital in Detroit.